MustangBio
    • About
      • About Mustang Bio
      • Leadership
      • Board of Directors
      • In the News
      • Contact
    • Our Approach
      • Our Approach
      • About CAR T Cell Therapy
      • Publications
    • Pipeline
      • Pipeline
      • Clinical Trials
    • Partnering
      • Partnering
      • Active Collaborations
    • Careers
    • Investor Relations
      • News & Events
      • Company Info
      • Financial Info
      • Stock Data
      • SEC Filings
      • Governance

    All SEC Filings

    Investors

    Investors

    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • SEC Filings

    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    Date Form Description PDF XBRL Pages
    07/03/24 424B5 Prospectus filed pursuant to Rule 424(b)(5) PDF 1
    06/28/24 PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition PDF 9
    06/28/24 SC 13D/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities PDF 4
    06/28/24 4 Statement of changes in beneficial ownership of securities PDF 1
    06/24/24 8-K Current report filing
    Documents expand_more
    EX-4.1
    EX-4.2
    EX-4.3
    EX-5.1
    EX-10.1
    EX-99.1
    EX-99.2
    PDF Document Table XBRL XAML 51
    06/24/24 D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. PDF 5
    06/21/24 424B5 Prospectus filed pursuant to Rule 424(b)(5) PDF 34
    06/20/24 424B5 Prospectus filed pursuant to Rule 424(b)(5) PDF 1
    06/12/24 EFFECT Notice of Effectiveness PDF 1
    06/10/24 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. PDF 1
    rss_feed Filing RSS
    • arrow_back
    • 1
    • …
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • …
    • 39
    • arrow_forward
    • Email Alerts
    • Contacts
    • RSS News Feed

    95 Sawyer Road, Suite 110 • Waltham, MA 02453

    781-652-4500 info@mustangbio.com

    Twitter Linkedin

    © Copyright 2025 Mustang Bio